These results suggest that miR-380 affects the expression of MMP-2 and p-AKT through targeted regulation of LIS1, thus participating in the regulation of cholangiocarcinoma cells, and confirm that miR-380 has an antitumor effect on cholangiocarcinoma. Here, AKT1 is linked to cholangiocarcinoma.